Delivery Order SPE2DB22D2006-SPE2DB25FW3UH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,102.08 to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets in quantities of 1,000 units. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance is scheduled for completion by August 21, 2025, with the product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,967.89 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. The award was made on September 12, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a...
- The Defense Logistics Agency awarded a $4,403.59 delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (180-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and identifies Conshohocken, Pennsylvania as the place of performance, aligning with AmerisourceBergen's corporate headquarters location. The delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.30 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.63 to AmerisourceBergen Drug Corp for 1,000 tablets of Metformin HCL ER 500 mg, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under a larger vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,487.16 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Metformin HCL 1,000 mg, with an ultimate completion date of September 19, 2025. This non-set-aside, firm fixed-price contract represents a small-value transaction within the pharmaceutical supply chain supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $1,250.16 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Metformin HCL ER 500 mg tablets (180-count units). This competitively awarded, firm fixed-price contract is classified as a child award under a larger indefinite delivery contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 3, 2025. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $4,513.21 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, issued one day prior on August 28, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) under a firm fixed price contract valued at $1,793.20. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,825.69 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,179,958 tablets of Metformin HCl ER 500 mg. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3UHDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,102.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets (1000-count units). This non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Metformin—a common generic diabetes management medication—reflects the company's ongoing role in supplying essential pharmaceutical commodities to support Defense Health Agency and other government healthcare operations worldwide through the DLA's competitive, firm fixed-price procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/22/25 |